1. Magnetic resonance imaging with targeted and standard biopsy was non-inferior for the detection of clinically significant cancers compared to standard biopsy only.
2. The detection of clinically insignificant cancers was less in the MRI group.
Evidence Rating Level: 1 (Excellent)
Study Rundown: Prostate cancer screening reduces prostate cancer mortality but has high...
1: Escalated-dose conformal radiotherapy with neoadjuvant androgen deprivation did not increase long-term, overall survival for patients with prostate cancer.
2: The escalated-dose regimen did result in prolonged biochemical progression-free survival, although with increased toxicity.
Evidence Rating: 1 (Excellent)
Study Rundown: This study randomized men with T1b-T3a,N0,M0 prostate cancer with PSA levels...
1. Primary care physicians accounted for 27% of the variance in whether an elderly man (>75 years old) received a PSA screen.
2. Variance in PSA screening among elderly men attributable to PCPs (0.27) is higher than mammography (0.10) and colorectal cancer (0.09) screening.
Evidence Rating Level: 3 (Average)
1. Black men under 65 are less likely to receive recommended diagnostic follow-up testing after an elevated prostate specific antigen (PSA) result than white men of the same age.
2. Poor diagnostic follow-up may help explain higher rates of prostate cancer mortality among black men.
Study Rundown: This study found...